Status:
COMPLETED
A Randomized Controlled Trial to Improve Medication Compliance Among Patients With Coronary Heart Disease
Lead Sponsor:
Emory University
Collaborating Sponsors:
American Heart Association
Conditions:
Coronary Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Coronary heart disease (CHD) is the most common cause of death in the United States. A common term for CHD is "blocked arteries." People with CHD or "blocked arteries" often have high blood pressure, ...
Eligibility Criteria
Inclusion
- Coronary heart disease, demonstrated by documentation of \> 30% stenosis of one or more coronary vessels on cardiac catheterization, history of coronary artery bypass graft surgery, history of angioplasty, or documented myocardial infarction.
Exclusion
- Current participation in another medication adherence study
- Too ill
- Does not manage their own medications
- No mailing address or telephone number
- Routine prescriptions filled outside of the Grady pharmacy system
- Psychiatric illnesses, overt delirium or dementia
- Visual acuity worse than 20/60
- Unable to communicate in English
- Already using a medication pill card
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
440 Patients enrolled
Trial Details
Trial ID
NCT00208832
Start Date
March 1 2004
End Date
March 1 2006
Last Update
December 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Grady Memorial Hospital
Atlanta, Georgia, United States, 30303